IOL Selection in Presbyopes With Comorbid Conditions (Part 2)

IOL Selection in Presbyopes With Comorbid Conditions Part 2
Media formats available:
Details
Presenters
  • Overview

    In this class, Drs. Marc Bloomenstein and Lindsey Bull discuss IOL selection in patients with comorbid conditions. By the end of this video, you will learn how to communicate about presbyopia and IOL options with patients who have borderline keratoconus, mild to moderate glaucoma, and epiretinal membrane.

    This activity is supported by unrestricted educational grants from AbbVie, Alcon, and Johnson & Johnson Vision.

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Define the prevalence and etiology of presbyopia and key characteristics of presbyopia progression from early to late-stage patients
    • Outline strategies for finding, communicating with, and educating patients about presbyopia-correction clinical outcomes, costs, risks, and benefits, including quality-of-life and quality-of-vision considerations
    • Describe how the latest presbyopia-correcting IOL technologies, multifocal contact lenses, and pharmaceutical presbyopia treatments can address outcomes in a new group of presbyopia patients, including those with comorbid conditions
    • Accreditation

      Sponsored by  

      Evolve Medical Education LLC (Evolve) is a COPE-accredited administrator. 
      This activity, COPE Activity Number 124946, is accredited by COPE for continuing education for optometrists. This course is approved for 0.25 hours of CE.

      Course #: 81393-GO
      Activity #: 124946

      COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.

    • Participation Method

      In order to obtain credit, proceed through the program, complete the posttest, evaluation and submit for credit.

    • Faculty and Disclosures

      Marc R. Bloomenstein, OD, FAAO

      Marc R. Bloomenstein, OD, FAAO

      Schwartz Laser Eye Center
      Director of Optometric Services
      Scottsdale, AZ


      Lindsey A. Bull, OD, FAAO

      Lindsey A. Bull, OD, FAAO

      Optometrist

      EyeCare Associates of South Tulsa

      Tulsa, OK


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

      The following faculty/staff members have the following financial relationships with ineligible companies.

      Marc R. Bloomenstein, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Aerie Pharmaceuticals, Allergan, Azura, Bausch + Lomb, Johnson & Johnson Vision, Kala Pharmaceuticals, OcuSoft, Sight Sciences, Sun Pharmaceutical Industries, and Tarsus. Grant/Research: Sight Sciences. Speaker’s Bureau: Allergan, Bausch + Lomb, Johnson & Johnson Vision, Kala Pharmaceuticals, Oyster Point Pharma, RVL, Sight Sciences, and Sun Pharmaceutical Industries.

      Lindsey A. Bull, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Allergan/AbbVie and Kala Pharmaceuticals. Speaker's Bureau: Allergan/AbbVie and Kala Pharmaceuticals.

      The Evolve staff, planners, and peer reviewer have no financial relationships with ineligible companies.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, The Fundingsland Group, AbbVie, Alcon, or Johnson & Johnson Vision.

      This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Release Date:

      Expiration Date:

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    Register

    We're glad to see you're enjoying Evolve Medical Education…
    but how about a more personalized experience?

    Register for free